© 2020 MJH Life Sciences and Patient Care Online. All rights reserved.
Ketamine used in patients with treatment-resistant depression operates via serotonin 1B receptors by way of a previously unknown mechanism of action, according to a new study from Sweden.
Analysis of EEG data from patients with major depressive disorder predicted response to SSRI treatment with accuracy of nearly 80%, according to a new study.
Highlights from a recent evidence-based review offer guidance on feasible depression treatments in primary care.